Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May 24:11:293.
doi: 10.3389/fnins.2017.00293. eCollection 2017.

Cannabinoid Receptor Signaling in Central Regulation of Feeding Behavior: A Mini-Review

Affiliations
Review

Cannabinoid Receptor Signaling in Central Regulation of Feeding Behavior: A Mini-Review

Marco Koch. Front Neurosci. .

Abstract

Cannabinoids are lipid messengers that modulate a variety of physiological processes and modify the generation of specific behaviors. In this regard, the cannabinoid receptor type 1 (CB1) represents the most relevant target molecule of cannabinoids so far. One main function of central CB1 signaling is to maintain whole body energy homeostasis. Thus, cannabinoids functionally interact with classical neurotransmitters in neural networks that control energy metabolism and feeding behavior. The promotion of CB1 signaling can increase appetite and stimulate feeding, while blockade of CB1 suppresses hunger and induces hypophagia. However, in order to treat overeating, pharmacological blockade of CB1 by the inverse agonist rimonabant not only suppressed feeding but also resulted in psychiatric side effects. Therefore, research within the last decade focused on deciphering the underlying cellular and molecular mechanisms of central cannabinoid signaling that control feeding and other behaviors, with the overall aim still being the identification of specific targets to develop safe pharmacological interventions for the treatment of obesity. Today, many studies unraveled the subcellular localization of CB1 and the function of cannabinoids in neurons and glial cells within circumscribed brain regions that represent integral parts of neural circuitries controlling feeding behavior. Here, these novel experimental findings will be summarized and recent advances in understanding the mechanisms of CB1-dependent cannabinoid signaling being relevant for central regulation of feeding behavior will be highlighted. Finally, presumed alternative pathways of cannabinoids that are not driven by CB1 activation but also contributing to control of feeding behavior will be introduced.

Keywords: anorexia; cachexia; cannabinoid receptor type 1; endocannabinoids; feeding behavior; hypothalamus; obesity; overeating.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Principles of central CB1 signaling in control of feeding behavior. (A) Retrograde signaling of eCBs at presynaptic CB1 impacts feeding (Bellocchio et al., 2010). (B) Postsynaptic CB1 at POMC neurons affects feeding in DIO (Morello et al., 2016). (C) Cannabinoids interfere with mitochondrial CB1 in hypothalamic feeding regulation (Koch et al., 2015). (D) Whether activity-dependent subcellular distribution of CB1(Thibault et al., 2013) accounts for control of food intake is still open. (E) Astroglial CB1 regulates the metabolic effects of leptin in cultured astrocytes (Bosier et al., 2013), and thus might contribute to astrocyte-dependent control of feeding behavior in the hypothalamus (Kim et al., 2014). (F) Enzymes of eCB synthesis or degradation control eCB levels in a spatial and temporal manner (Pertwee, 2014). Moreover, eCBs not only function as CB1 ligands, but also as substrates of specific enzymes, such as lipoxygenases (LOX), cyclooxygenases (COX), or cytochrome P450, supporting the idea that the ECS might also transmit metabolic effects independently from CB1 signaling (non-CB1).

References

    1. Aigner M., Treasure J., Kaye W., Kasper S., Disorders W.T.F.O.E. (2011). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World J. Biol. Psychiatry 12, 400–443. 10.3109/15622975.2011.602720 - DOI - PubMed
    1. Alonso-Alonso M., Woods S. C., Pelchat M., Grigson P. S., Stice E., Farooqi S., et al. . (2015). Food reward system: current perspectives and future research needs. Nutr. Rev. 73, 296–307. 10.1093/nutrit/nuv002 - DOI - PMC - PubMed
    1. Alpar A., Harkany T. (2013). Orexin neurons use endocannabinoids to break obesity-induced inhibition. Proc. Natl. Acad. Sci. U.S.A. 110, 9625–9626. 10.1073/pnas.1307389110 - DOI - PMC - PubMed
    1. Argente-Arizon P., Guerra-Cantera S., Garcia-Segura L. M., Argente J., Chowen J. A. (2017). Glial cells and energy balance. J. Mol. Endocrinol. 58, R59–R71. 10.1530/JME-16-0182 - DOI - PubMed
    1. Baufeld C., Osterloh A., Prokop S., Miller K. R., Heppner F. L. (2016). High-fat diet-induced brain region-specific phenotypic spectrum of CNS resident microglia. Acta Neuropathol. 132, 361–375. 10.1007/s00401-016-1595-4 - DOI - PMC - PubMed

LinkOut - more resources